Oncology Poster Tour

Moderator

Abril Seyahian, Radboudumc-Department for Health Evidence, Nijmegen, Netherlands

This tour will take place during Poster Session 1, Poster will be hung from 10:30 - 13:30. Posters featured in this tour include:

PT1: A Contemporary Approach to Determining Cancer Patients Healthcare Resources Utilization
PT2: Frequency and Impact of External Comparator Arms in Oncology HTA Assessments With Single-Arm Trials in the UK, France, and Germany From 2014 to 2024
PT3: Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect
PT4: Developing a Novel Model Structure for Evaluating Treatment Sequences in Oncology Pathways: A Pilot in Non-Small Cell Lung Cancer
PT5: Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
PT6: Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-Analysis

Code

024